These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 4092102)

  • 1. [Symposium on cancer of the prostate. 11-12 March 1985, Paris].
    Bull Cancer; 1985; 72(6):518-84. PubMed ID: 4092102
    [No Abstract]   [Full Text] [Related]  

  • 2. [Symposium on cancer of the prostate. 11-12 March 1985 (Paris)].
    Bull Cancer; 1985; 72(5):379-466. PubMed ID: 4074909
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer. Part A: Research, endocrine treatment, and histopathology. Proceedings of the Second International Symposium on Prostate Cancer. Paris, France, June 16-18, 1986.
    Prog Clin Biol Res; 1987; 243A():1-586. PubMed ID: 3658996
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate cancer. Part B: Imaging techniques, radiotherapy, chemotherapy, and management issues. Proceedings of the Second International Symposium on Prostate Cancer. Paris, France, June 16-18, 1986.
    Prog Clin Biol Res; 1987; 243B():1-545. PubMed ID: 3659015
    [No Abstract]   [Full Text] [Related]  

  • 5. Symposium issue: prostate cancer 2008.
    Bissada NK
    J Ark Med Soc; 2008 Sep; 105(3):54. PubMed ID: 18828469
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical analysis of double cancer involving bladder and prostate].
    Yumura Y; Oogo Y; Takase K; Kato Y; Hamano A; Noguchi S; Fukuda M; Satomi Y
    Hinyokika Kiyo; 2006 Apr; 52(4):255-8. PubMed ID: 16686351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of early prostate cancer (introduction).
    Haas GP
    In Vivo; 1994; 8(3):403-5. PubMed ID: 7803726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in prostate cancer.
    Talcott JA; Clark JA
    Eur J Cancer; 2005 Apr; 41(6):922-31. PubMed ID: 15808958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study on prostatic cancer detected incidentally by transurethral resection of the prostate].
    Hayakawa T; Mitsuya H; Kojima M; Hayase Y
    Hinyokika Kiyo; 2002 Jan; 48(1):13-6. PubMed ID: 11868378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
    Eiseman JL; Rogers FA; Guo Y; Kauffman J; Sentz DL; Klinger MF; Callery PS; Kyprianou N
    Cancer Res; 1998 Nov; 58(21):4864-70. PubMed ID: 9809992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of COX-2 in prostatic cancer and benign prostatic hyperplasia].
    Zang T; Sun F; Li Y
    Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):702-3. PubMed ID: 11769607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indication of repeat prostate biopsy for the diagnosis of prostate cancer].
    Hori J; Okuyama M; Azumi M; Kato Y; Saga Y; Hashimoto H; Tokumitsu M; Kakizaki H
    Hinyokika Kiyo; 2006 Nov; 52(11):835-8; discussion 838-9. PubMed ID: 17176864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen and prostate cancer.
    Rosalki SB; Rutherford FJ
    Int J Clin Pract; 2000 Nov; 54(9):611-3. PubMed ID: 11220990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
    Ramos CG; Carvahal GF; Mager DE; Haberer B; Catalona WJ
    J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection.
    Kline EE; Treat EG; Averna TA; Davis MS; Smith AY; Sillerud LO
    J Urol; 2006 Nov; 176(5):2274-9. PubMed ID: 17070311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do all patients with high-grade prostatic intraepithelial neoplasia on initial prostatic biopsy eventually progress to clinical prostate cancer?
    Izawa JI; Lega I; Downey D; Chin JL; Luke PP
    BJU Int; 2005 Aug; 96(3):320-3. PubMed ID: 16042722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finasteride decreases the risk of prostatic intraepithelial neoplasia.
    Thompson IM; Lucia MS; Redman MW; Darke A; La Rosa FG; Parnes HL; Lippman SM; Coltman CA
    J Urol; 2007 Jul; 178(1):107-9; discussion 110. PubMed ID: 17499284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage.
    Meid FH; Gygi CM; Leisinger HJ; Bosman FT; Benhattar J
    J Urol; 2001 May; 165(5):1802-5. PubMed ID: 11342979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review.
    Saad M; Abdel-Rahim M; Abol-Enein H; Ghoneim MA
    BJU Int; 2008 Dec; 102(11):1544-50. PubMed ID: 18565169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer.
    Vallbo C; Wang W; Damber JE
    BJU Int; 2004 Jun; 93(9):1339-43. PubMed ID: 15180634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.